Standing at the forefront of cancer screening innovation, GRAIL leverages the power of next-generation DNA sequencing, population-scale clinical studies, and state-of-the-art machine learning to help detect many of the deadliest cancer types. GRAIL engages a multidisciplinary team of scientists, engineers, and physicians, collaborating to transform cancer screening. Visit GRAIL.com or Galleri.com to learn about the Galleri® multi-cancer early detection test.
GRAIL has the mission to detect cancer early when it can be cured. The Galleri® test screens for multiple cancers through a simple blood draw. When a shared signal is detected, it can predict the cancer signal origin. For important safety information visit Booth #1326 or Galleri.com.